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Ferroportin (FPN1), the sole characterized mamma-
lian iron exporter, has an iron-responsive element
(IRE) in its 50 untranslated region, which ensures that
its translation is repressed by iron regulatory proteins
(IRPs) in iron-deficient conditions to maintain cellular
iron content. However, here we demonstrate that
duodenal epithelial and erythroid precursor cells
utilize an alternative upstream promoter to express
a FPN1 transcript, FPN1B, which lacks the IRE and
is not repressed in iron-deficient conditions. The
FPN1B transcript encodes ferroportin with an iden-
tical open reading frame and contributes significantly
to ferroportin protein expression in erythroid precur-
sors and likely also in the duodenum of iron-starved
animals. The identification of FPN1B reveals how
FPN1 expression can bypass IRP-dependent repres-
sion in intestinal iron uptake, even when cells
throughout the body are iron deficient. In erythroid
precursor cells, we hypothesize that FPN1B expres-
sion enhances real-time sensing of systemic iron
status and facilitates restriction of erythropoiesis in
response to low systemic iron.
INTRODUCTION
Iron is an essential element for living organisms, as it is required
for activity of molecules involved in a series of crucial physiolog-
ical events such as oxygen transport, mitochondrial respiration,
and DNA synthesis. However, because of its prooxidant proper-
ties, excess iron can potentially damage DNA, lipids, and
proteins, leading to cell death and tissue dysfunction. As
mammals do not have a dedicated iron secretory pathway,
organisms regulate body iron stores largely by regulating intes-
tinal iron absorption, in part through the hepcidin-ferroportin
interaction (Nemeth and Ganz, 2006; Darshan and Anderson,
2007; Wrighting and Andrews, 2008).
FPN1 (Donovan et al., 2000), also known as IREG1 (McKie
et al., 2000) or MTP1 (Abboud and Haile, 2000), is the sole iron
exporter protein identified thus far (Donovan et al., 2005). It is
highly expressed in numerous cells, including two types that
are important in systemic iron homeostasis, the duodenal enter-
ocytes, where FPN1 is responsible for transporting dietary ironacross the basolateral membrane into the blood stream (for
iron uptake) (Abboud and Haile, 2000; Donovan et al., 2000;
McKie et al., 2000), and the reticuloendothelial macrophages,
where FPN1 exports iron from the cytosol into the blood stream
(for iron recycling) (Yang et al., 2002; Knutson et al., 2003; Delaby
et al., 2005). In humans, some mutations in the coding region of
FPN1 lead to autosomal dominant iron overload (Pietrangelo,
2004). In mice, targeted deletion of FPN1 causes embryonic
lethality due to the inability to transfer iron from the mother to
FPN1-deficient embryos, while conditional knockout of FPN1
in the duodenum causes a significant anemia in mice, empha-
sizing its importance in iron absorption (Donovan et al., 2005).
Ferroportin expression is regulated at several levels, including
presumed transcriptional regulation in the duodenal mucosa
and macrophages (McKie et al., 2000; Knutson et al., 2003),
translational regulation by the iron-responsive element (IRE)/
IRP regulatory system (Abboud and Haile, 2000; McKie et al.,
2000; Liu et al., 2002; Lymboussaki et al., 2003), and posttrans-
lational regulation by the action of hepcidin, a small peptide
hormone secreted by hepatocytes in response to increased
iron abundance (Park et al., 2001; Pigeon et al., 2001). Circu-
lating in the blood stream, hepcidin can bind to FPN1, which
results in the internalization of FPN1 and degradation of FPN1
in lysosomes. Reduced export of iron fromduodenal enterocytes
and macrophages contributes to systemic iron deficiency (Nem-
eth et al., 2004). Conversely, in iron-depleted animals, hepcidin
expression is suppressed, FPN1 degradation is reduced, and
more iron is therefore absorbed to satisfy systemic iron
demands. Thus, by feedback regulation, hepcidin can interact
with FPN1 to prevent systemic iron overload. Most types
of hemochromatosis result from dysfunction of the hepcidin-
FPN1 interaction, providing compelling evidence for the impor-
tance of the hepcidin-ferroportin interactions in regulation
of systemic iron homeostasis (Nemeth and Ganz, 2006;
Pietrangelo, 2006; Darshan and Anderson, 2007; Wrighting and
Andrews, 2008).
Similar to numerous transcripts that encode iron metabolism
proteins, FPN1 messenger RNA (mRNA) has an IRE in its 50
untranslated region (UTR), and its expression is translationally
regulated by iron regulatory proteins (IRP1 and IRP2) (Abboud
and Haile, 2000;McKie et al., 2000; Liu et al., 2002; Lymboussaki
et al., 2003). Other iron metabolism genes that contain IREs
include L- and H-ferritin, an erythroid isoform of aminolevulinate
synthase (e-ALAS), and mitochondrial aconitase, all of which
contain 50IREs that mediate translational repression, as well as
the transferrin receptor1 (TfR1) and one isoform of divalent metalCell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc. 461
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likely affect mRNA stability (Rouault, 2006; Wallander et al.,
2006). IRE-binding activities of IRPs are regulated by intracellular
iron status and are activated by iron deficiency. Binding by IRPs
enables cells to replenish cytosolic iron by increasing iron uptake
through TfR1 and DMT1 while simultaneously decreasing iron
sequestration in ferritin and suppressing iron export through
FPN1.
FPN1 protein levels have been reported to be decreased in the
duodenum of high-iron diet animals and increased in the
duodenum of low-iron diet animals (Abboud and Haile, 2000;
McKie et al., 2000). However, in iron-deficient animals, activation
of IRPs by iron deficiency would normally be expected to repress
translation of FPN1, which raises the question of how iron-defi-
cient enterocytes circumvent repression by IRE/IRP machinery
to produce FPN1 protein. The IRE in FPN1 transcript was previ-
ously shown to be functional in reporter and competition assays
(Abboud and Haile, 2000; McKie et al., 2000; Liu et al., 2002;
Lymboussaki et al., 2003). Moreover, in mice lacking intestinal
expression of IRPs, FPN1 protein levels were significantly
increased, whereas FPN1 mRNA levels remained constant,
providing evidence that FPN1 was regulated by the IRE/IRP
machinery in vivo (Galy et al., 2008). The IRE/IRP machinery is
thought to be highly functional in duodenal enterocytes, as
protein levels of L- and H-ferritin, two genes that contain 50IREs,
were dramatically decreased in the duodenum of mice main-
tained on a low-iron diet although their mRNA levels remained
constant (McKie et al., 1996; Pountney et al., 1999). As FPN1
expression should also be similarly translationally repressed by
IRPs, we considered the possibility that a non-IRE-containing
FPN1 transcript that could evade repression by the IRE/IRP
system in iron deficiency might be expressed in duodenum to
allow active export of iron into the blood stream tomeet systemic
iron demands.
In this work, we performed 50-rapid amplification of comple-
mentary DNA (cDNA) end assays (RACE) on mouse cDNA
libraries and identified a non-IRE-containing transcript of FPN1
generated from an alternative upstream promoter. Characteriza-
tion of its expression profiles and regulation by iron in vivo and
in vitro suggested that this non-IRE-containing ferroportin
transcript plays an important physiological role in two distinct
cell types: in duodenal mucosal cells, where it likely facilitates
intestinal iron uptake in iron-deficient animals, and in erythroid
precursors, where it drives iron export activity and perhaps
renders erythroid precursors more responsive to changes in
systemic iron status.
RESULTS
FPN1 Protein Increased in the Duodenum
of Iron-Deficient Mice
To evaluate expression levels of FPN1 in mice maintained on
a low-iron diet, immunofluorescence experiments were per-
formed on duodenal sections of mice maintained on a low-iron
diet and increased expression of FPN1 was detected throughout
the duodenal epithelial cells, compared with mice maintained on
a high-iron diet (Figure 1A). As a confirmation of the iron status of
these mice, Perls’ Prussian blue staining on the duodenal and
splenic sections showed more iron in tissues from animals on462 Cell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc.a high-iron diet compared to a low-iron diet (Figure 1B). Western
blots confirmed that there was strong expression of FPN1 in the
duodenum of low-iron diet mice and little if any in the duodenum
of high-iron diet mice (Figure 1C). The increased expression of
FPN1 in low-iron diet mice was consistent with previous reports
in which increased expression of FPN1 protein (Abboud and
Haile, 2000; McKie et al., 2000) and mRNA (McKie et al., 2000)
was reported in duodenal samples of iron-deficient animals.
For comparison, expression levels of other IRE-containing
genes in the intestinal mucosa were compared in animals on
a low- versus high-iron diet, and increased expression of
DMT1 and TfR1 and decreased expression of FtL and FtH
proteins were observed in animals on a low-iron diet (Figure 1C).
At the mRNA level, transcripts encoding components of the iron
uptake pathway, including FPN1, DMT1, TfR1, and Dcytb, were
significantly increased (Figure 1D), suggesting that, in addition to
the well-known stabilization of the TfR1 mRNA, the transcrip-
tional regulation of these genes is also important. Comparing
the expression of ferritin mRNA levels with their protein levels,
duodenal regulation of ferritin appeared to be almost entirely
translational, as mRNA levels did not change, whereas protein
levels increased significantly, indicating the IRE/IRP machinery
was highly activated (Figures 1C and 1D) (McKie et al., 1996;
Pountney et al., 1999). The mRNA level of FPN1 was about
5-fold elevated on the low-iron diet. However, because the
FPN1 transcript contains a functional 50IRE in its mRNA (Abboud
and Haile, 2000; McKie et al., 2000; Liu et al., 2002; Lymboussaki
et al., 2003), its translation was expected to be repressed, similar
to FtL and FtH, both of which are encoded by transcripts that
contain 50IREs as well. Therefore, the strikingly high expression
of FPN1 protein on the low-iron diet (Figure 1C, top panel) was
inconsistent with the expectation that translational repression
would be mediated by the 50IRE in the FPN1 mRNA. To better
understand FPN1 expression in the duodenum, we undertook
to carefully analyze the FPN1 transcript.
A Transcript of FPN1 that Lacked an IRE Was Identified
by RACE
To fully characterize the 50-end of the FPN1 transcript, we
performed 50-RACE assays with a Marathon-Ready mouse
cDNA library. Although seven of the nine clones sequenced
were almost identical to the FPN1 mRNA sequence provided
by the Entrez Gene NM_016917, two of them contained a novel
96 bp sequence in the 50-end of the transcript. By alignment with
the genomic DNA, we found that this 96 bp sequence was from
a new exon (exon 1b) located 1161 bp 50 of the AUG (initiator
methionine of the open reading frame) and 845 bp 50 of the
previously annotated exon 1 (exon 1a) (Figure 2A). In the newly
identified isoform, exon 1bwas connected by alternative splicing
to a potential splice acceptor site within exon 1a, which was 30 of
the IRE, generating a transcript that lacked the IRE. Hereafter,
we refer to the transcript that lacked the IRE as FPN1B and the
transcript that contained the IRE as FPN1A. FPN1B consists of
nine exons, including exon 1b, a truncated form of exon 1a,
and the remaining seven exons, whereas FPN1A consists of
eight exons, extending from exon 1a to exon 8 (Figure 2A).
To confirm the existence of FPN1B, we designed three
primers, including one that was specific for the 50-end of
FPN1A (F1), one that was specific for exon 1b (F2), and a reverse
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FPN1B Transcript in Duodenal and Erythroid Cellsprimer specific for exon 2 (Primer R), a region that was shared by
both transcripts (Figure 2A). With primers F1/R, we got a band of
356 bp as expected in cDNA from spleen, kidney, and
duodenum. However, with primers F2/R, we got three distinct
bands in all of the three tissues tested (Figure 2B). Sequencing
of each band showed that the largest band was derived from
a transcript in which exon 1b connected to a nucleotide of
exon 1a that was 145 bp 50 of the AUG start codon (145), as
was initially observed in the RACE assays. The two lower bands
were generated by splicing from exon 1b to nucleotides at posi-
tions 102 and 64 of exon 1a, respectively (Figure 2A). Thus,
there were actually three FPN1B transcripts, which we have
deposited in GenBank: FPN1B1 (accession number
FJ207421), intron acceptor site 145; FPN1B2 (accession
number FJ207422), acceptor site102; and FPN1B3 (accession
number FJ207423), acceptor site 64. For each of the three
splice acceptor sites, the intron ends with ‘‘AG,’’ a dinucleotide
sequence typical of intron acceptor sites. However, according
to genome sequence compiled in the Entrez Gene, the genomic
Figure 1. Expression of FPN1 Increased in
the Duodenum of Mice Maintained on a
Low-Iron Diet
(A) FPN1 expression (red) was detected with
a polyclonal anti-FPN1 antibody and visualized
by immunofluorescence in the duodenal sections
of low- and high-iron diet mice. The nucleus was
counterstained with DAPI (blue).
(B) Prussian blue staining revealed more iron (blue)
in the intestinal mucosa and spleen of high-iron
diet mice than that of low-iron diet mice. Mice
were counterstained with fast red for nucleus
(red) and cytoplasm (pink).
(C) Western blots revealed high expression of
FPN1 in the lysate from duodenum of mice on
a low-iron diet (40 mg per lane). Levels of DMT1
and TfR1 increased on the low-iron diet, whereas
FtL and FtH decreased.
(D) Northern blots revealed that mRNA expression
of FPN1, DMT1, TfR1, and Dcytb increased in
duodenum of mice on a low-iron diet, whereas
FtL mRNA did not change.
sequence for the intron acceptor site of
FPN1B2 ends with ‘‘AC,’’ and only 2 of
12 sequences in the Evidence Viewer
are ‘‘AG,’’ whereas the others are ‘‘AC,’’
indicating that a single nucleotide poly-
morphism exists in this site and FPN1B2
may not be expressed in all mouse
strains.
The 50UTR of FPN1B Did Not
Mediate Translational Repression
in Iron-Starved Cells
To evaluate the regulation of the 50UTR of
the FPN1B transcript, we cloned the
50UTRs of FPN1A and FPN1B into
a pGL3 vector, in which a SV40 promoter
drives transcription to produce a lucif-
erase chimeric mRNA with the FPN1A
or FPN1B 50UTR as its 50UTR, making it possible to check the
translational regulation of FPN1A or FPN1B 50UTR in vivo. In
the rat intestinal epithelial cell line IEC6, the expression of the
FPN1A/luciferase construct decreased with iron starvation to
20%of the level in iron-replete cells (Figure 2C). In contrast, there
was no change of the luciferase activity among the three FPN1B
isoforms expressed in IEC6 cells subjected to different iron
conditions. Similar results were observed in CACO2 and 293
cells (Figures S1A and S1B). Thus, none of the three identified
50UTRs of FPN1B was regulated by iron.
FPN1B Was Specifically Expressed in Duodenum
To characterize the expression profile of FPN1A and FPN1B in
different tissues, we performed northern blots with transcript-
specific probes. With the FPN1B probe, a band of about 3.4 kb
was specifically identified in duodenum (Figure 3A). In contrast,
the FPN1A band of about 3.4 kb was highly expressed in spleen,
liver, duodenum, and kidney. With a probe covering the coding
region common to both transcripts, expression levels mirroredCell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc. 463
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(A) Schematic representation of genomic (top) and transcript structure (bottom) of FPN1. FPN1 has a total of nine exons (boxes 1b, 1a, and 2–8; introns
depicted as lines), and the IRE and AUG codon are located in exon 1a. By alternative use of exon 1a or 1b, two FPN1 transcripts are generated. The
FPN1A transcript extends from exon 1a and includes exons 2–8, producing a transcript that contains an IRE in its 50UTR. The FPN1B transcript commences
with exon 1b and includes a portion of exon 1a that is 30 of the IRE (from nucleotide 145, 102, or 64 depending on different acceptor sites), as well as
exons 2–8, producing a transcript that does not have an IRE. Primers F1, F2, and R, as indicated on the graphic, were used for PCR amplification of FPN1A
and FPN1B.
(B) PCR amplification of FPN1A (lanes 2, 5, and 8) and FPN1B (lanes 3, 6, and 9) using cDNA generated from spleen, kidney, and duodenum revealed three
bands that corresponded to the use of three distinct acceptor sites within exon 1a of FPN1B. FPN1 was amplified by a pair of primers located within the open
reading frame (lanes 4, 7, and 10). The expected sizes for each of the bands were 596 bp (FPN1), 356 bp (FPN1A), and 312, 269, and 231 bp (FPN1B). PCR
products were separated on a 2% agarose gel.
(C) Expression of the FPN1B reporter construct was not repressed in iron starvation conditions. The 50UTRs of FPN1A and FPN1B were cloned into the pGL3
luciferase vector, and then 1 mg of those vectors with 0.1 mg of renilla luciferase vector were transfected into IEC6 cells. One day later those cells were treated
with either 200 or 100 mM FAC or 100 or 200 mM DFO for 24 hr. The luciferase activity was measured by a dual luciferase activity assay. FPN1B1, B2, and B3
represent the longest, middle, and shortest transcripts, respectively. Data are presented as mean ± SD.464 Cell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc.
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FPN1B Transcript in Duodenal and Erythroid CellsFigure 3. The FPN1B Transcript Was Highly Expressed in Duodenum and Bone Marrow
(A) Total RNA of multiple tissues was probed with FPN1B- or 1A-specific probes in northern blots.
(B) qRT-PCR was used to check the expression of FPN1B and FPN1A in cDNA of mouse tissues. The results revealed that FPN1B was specifically expressed in
duodenum and bone marrow. Data are presented as mean ± SD.
(C) qRT-PCR was used to check the expression of FPN1B, FPN1A, total FPN1, DMT1, Dcytb, TfR1, and FtL in cDNA from different parts of intestinal tract.
The expression level was normalized to b-actin. Data are presented as mean ± SD.
(D) In situ hybridization to check the expression of the FPN1B and 1A transcripts revealed that both were expressed in duodenal mucosa cells.those for FPN1A. Because the difference in size between FPN1B
and FPN1A is very small compared to the full-length transcript,
changing by 74–154 bp out of 3400 bp total, we could not
distinguish the FPN1B from FPN1A bands in northern blots
performed using the common probe.
To quantitatively compare the abundance of these two
transcripts in different tissues, quantitative real-time PCR
(qRT-PCR) was performed and the results were consistent with
northern blot results (Figure 3B). FPN1B was highly expressed
in duodenum. Interestingly, FPN1B was also significantly ex-
pressed in bone marrow. FPN1B accounted for 25% of total
FPN1 mRNA in duodenum and about 40% in bone marrow
(Figure 3B). In contrast, FPN1B accounted for less than 6% of
total FPN1 in other tissues. In different parts of the intestinal
tract, FPN1B was expressed mainly in duodenum, as was
FPN1A and Dcytb (Figure 3C). DMT1 expression was highest
in duodenum, whereas TfR1 expression was lowest in
duodenum among four parts of intestinal tract, and the expres-sion of ferritin was comparable to GAPDH expression levels
(Figure 3C). In situ hybridization studies revealed that both
FPN1A and 1B transcripts were expressed strongly in entero-
cytes (Figure 3D).
Duodenal Expression of FPN1B Increased in Animals
on a Low-Iron Diet
Because FPN1 protein levels increased in the duodenum of
animals on a low-iron diet (Figures 1A and 1C), we evaluated
FPN1B and FPN1A mRNA levels in northern blots of duodenal
RNA from animals on low- versus high-iron diets, and we found
that both FPN1B and FPN1AmRNA levels significantly increased
on the low-iron diet, similar to levels of total FPN1mRNA (Figures
1D and 4A). The expression of FPN1B and FPN1A in four parts of
intestinal tract on low- versus high-iron diet were also studied by
qRT-PCR. For FPN1B, mRNA levels increased 3-fold in the
duodenum and jejunum on the low-iron diet and FPN1A mRNA
levels increased more than 5-fold in duodenum and jejunum onCell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc. 465
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FPN1B levels in ileum and colon on the low-iron diet (Figure 4B).
Transcript levels of DMT1 andDcytbwere dramatically increased
on the low-iron diet in duodenum and jejunum, and TfR1 levels
increased moderately, but ferritin and GADPH mRNA levels
were unchanged in the intestinal tract from animals on a low-
iron diet.
FPN1B Was Specifically Expressed
in Erythroid Cells
To compare the FPN1B transcript in bone marrow and
duodenum, we performed northern blots with the FPN1B-
specific probe on RNA from bonemarrow andmouse erythroleu-
kemia cell (MEL) cells (Figure 5A). In those two samples, we de-
tected a 3.4 kb transcript similar to the FPN1B transcript in
duodenum, and PCR results showed that all of the three subtran-
scripts of FPN1B were expressed in erythroid cells of mouse
bone marrow (Figure 5B) and in erythroid precursor cell lines,
MEL and G1E cells (Figure S2). We also checked the expression
of FPN1B in other cell lines, including mouse small intestinal
Figure 4. Expression of the FPN1B Transcript Increased
in the Duodenum of Mice Maintained on a Low-Iron Diet
Northern blot (A) and qRT-PCR (B) were used to check the expression
of FPN1B and other iron genes in different parts of intestinal tract.
The results revealed that FPN1B expression increased on a low-iron
diet treatment. Data are presented as mean ± SD. *p < 0.05 and
**p < 0.01, comparing with corresponding high-iron diet.
epithelium (MSIE) cells, MODE-k cells, RAW264.7 cells,
and J774a.1 cells, but we did not detect FPN1B expres-
sion in nonerythroid cell lines (data not shown). Quantifica-
tion of FPN1B expression with qRT-PCR showed that
FPN1B accounted for more than 60% of total FPN1
transcript in MEL and G1E cells in comparison with 40%
in bone marrow (Figure 5C). MEL cells have some charac-
teristics of BFU-E and CFU-E cells, and G1E cells are
considered to represent proerythroblast cells that also
have characteristics of BFU-E cells (Anguita et al., 2004).
The high expression of FPN1B in MEL and G1E cells
revealed that FPN1B was expressed highly in erythroid
precursor cells. To determine which cell type in bone
marrow was responsible for high expression of FPN1B,
we sorted bone marrow cells using antibodies to either
macrophages (CD11b) or differentiating erythroid cells
(Ter119). Quantification of ferroportin 1B and 1A tran-
scripts revealed that almost all of the FPN1B was in cells
of the erythroid lineage, where it accounted for more
than 60% of FPN1 mRNA levels. In contrast, FPN1B tran-
script levels were 10-fold lower in macrophages, and
comprised less than 15% of total FPN1 mRNA
(Figure 5D). At the protein level, there was more than five
times as much ferroportin protein in erythroid cells as in
macrophages or other bone marrow cells (Figure 5E),
andTfR1mRNAandprotein levelswere high, as expected,
in erythroid cells (Figures 5E and S3). Comparison of the
expression of FPN1 transcripts with protein levels re-
vealed that FPN1B mRNA levels correlated well with ferroportin
protein levels in erythroid cells.
FPN1B Accounts for Most Ferroportin Expression
in Erythroid Cells
To better characterize the role of FPN1B in erythroid cells, we
obtained G1E-ER4 cells, an erythroid precursor cell line that
expresses GATA-1 conditionally under control of estrogen
receptor ligand binding domain, and we induced synchronous
erythroid maturation for up to 72 hr by estradiol treatment (Weiss
et al., 1997; Rylski et al., 2003; Welch et al., 2004). At 0, 6, 12, 24,
36, 48, 60, and 72 hr after induction, we quantified levels of
FPN1A and 1B transcripts (Figure 5F), and we discovered that
FPN1B accounted for most FPN1 transcripts at early stages of
differentiation. At late stages of differentiation when hemoglobin
mRNA levels were high (Figure S4), levels of FPN1A increased,
but FPN1 protein levels did not increase along with FPN1A
transcript levels. FPN1 protein levels reflected the levels of
FPN1B transcript (Figures 5F and 5G), suggesting that FPN1A
expression was translationally repressed by IRPs in the466 Cell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc.
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FPN1B Transcript in Duodenal and Erythroid CellsFigure 5. FPN1B Was Specifically Expressed in Erythroid Precursor Cells and Decreased with Cell Differentiation
(A) Northern blot showed that FPN1B expressed in bone marrow and MEL cells was identical in size to the approximately 3.4 kb duodenal FPN1B transcript.
(B) PCR experiments verified that all of the three FPN1B subtranscripts were expressed in mouse Ter119-positive erythroid cells.
(C) qRT-PCR to check the expression of FPN1B, FPN1A, and FPN1 mRNA expression in MEL cells, G1E cells, and mouse bone marrow, normalized with actin,
revealed high FPN1B expression in these two erythroid precursor cell lines. Data are presented as mean ± SD.
(D) qRT-PCR results showed that FPN1B was specifically expressed in Ter119-positive erythroid cells (Ery) rather than CD11b-positive macrophages (Mac) or
cells depleted of erythroid cells andmacrophages. Mac1 (macrophage antigen a) and Hbb (hemoglobin b chain) were used as controls to verify the isolation. The
expression levels of these genes were normalized with actin. Data are presented as mean ± SD.Cell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc. 467
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we found that TfR1 and FtL in both mRNA and protein levels
were significantly increased during erythroid differentiation
(Welch et al., 2004), while there was no significant change of
IRP1 or IRP2 expression (Figures 5G and S4). These results indi-
cated that FPN1B is the major source of encoded FPN1 in
erythroid precursors.
The FPN1B Promoter Has Gut and Erythroid-Specific
Transcriptional Regulation Elements
To investigate how FPN1B expression is regulated, we studied
its promoter and the potential transcriptional elements. A CpG
island was annotated in GeneBuilder and Map Viewer in the
FPN1B promoter region. CpG islands are found in the promoters
of about 56% of human genes (Antequera and Bird, 1993).
Sequence alignment of FPN1B promoter showed high conserva-
tion between mouse and human sequences in the 200 bp region
50 of the transcription initiation site, which contained conserved
consensus binding sites for several transcription factors,
including GATA, EKLF, and GKLF (Figure 6A). FPN1B and
FPN1A promoter constructs were transfected into mammalian
cell lines such asMEL cells, K562 cells, CACO2 cells, MSIE cells,
RAW264.7 cells, and HepG2 cells. Though the FPN1A promoter
construct displayed promoter activity in all of the cell lines
tested, the FPN1B promoter was active only in MEL and K562
cells, consistent with its endogenous pattern of mRNA expres-
sion among cell lines (Figures 6B and 5C). Serial deletion of the
promoter region showed that the major elements of the FPN1B
promoter were located within the 133 bp region 50 of the tran-
scriptional initiation site (Figures 6C and S5A). To characterize
which transcriptional elements were essential for its promoter
activity, each of the putative transcriptional elements in the
FPN1B promoter was mutagenized. In MEL and K562 cells,
mutation of the GATA-114 site, EKLF/GKLF/SP1-71 (members
of the KLF family share similar binding sites [Kaczynski et al.,
2003]) site, and GATA-29 site resulted in significant loss of
promoter activity, which indicated that these sites were impor-
tant in FPN1B promoter activity (Figure 6D and Figure S5B)
and that GATA1, GATA2, EKLF, GKLF, and SP1 all probably
regulated FPN1B expression. GATA1, GATA2, and EKLF are
erythroid-specific transcriptional factors (Miller and Bieker,
1993; Weiss and Orkin, 1995), whereas GKLF is specifically
expressed in the gastrointestinal tract (Shields et al., 1996).
The regulation of FPN1B by these transcription factors is consis-
tent with its specific expression in duodenum and erythroid cells.
DISCUSSION
Here, we have reported the identification of a ferroportin tran-
script, FPN1B, which lacks an IRE and is not subject to repres-
sion by the IRE/IRP system in iron-deficient conditions. Although468 Cell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc.FPN1B was generated from an alternative promoter, it shared
the same open reading frame as FPN1A. FPN1Bwas specifically
expressed in two locations: in the duodenum, especially in enter-
ocytes, and in erythroid precursor cells. The discovery of FPN1B
in duodenal epithelial cells helps to resolve the problem of how
enterocytes can continue to export iron into the circulation
when they are iron depleted. The discovery that the FPN1B
transcript encodes most of the ferroportin protein expressed in
erythroid precursors adds an important new dimension to mech-
anisms of how erythroid precursor cells sense systemic iron
levels and how their differentiation is attuned to iron status
changes during erythropoiesis.
Discovery of a second ferroportin promoter and transcript fits
well with the recent discovery that many nonproductive tran-
scriptional initiation events occur in the vicinity of established
promoters, some of which may produce mRNAs with altered
translation efficiency, allowing transcripts to evolve to meet
specific physiological needs (Buratowski, 2008). Alternative tran-
scripts of FPN1 have previously been observed in human
erythroid cells (Cianetti et al., 2005), where one of the major tran-
scripts, referred to as FPNIIB, is homologous to the mouse
FPN1B that we reported here. Along with the conservation
between human and mouse in the promoter sequence and puta-
tive transcription factor binding sites, this human transcript
suggests that FPN1B is conserved between human and mouse
and likely also in other mammals. Although the FPN1B transcript
has not been previously observed in wild-type mice, it was
observed in polycythaemia (Pcm)mice (Mok et al., 2004a), which
were generated by radiation mutagenesis. Pcm mice contain
a 58 bp deletion in the FPN1A promoter, which alters the tran-
scription start site and eliminates the IRE in the 50UTR. Among
ten FPN1 clones sequenced for Pcm mice, four clones included
portions of exon 1b reported here, including one that was iden-
tical to FPN1B and three others that started from the middle of
exon 1b. The remaining clones initiated from exon 1a, but the
transcription start sites were 30 of the IRE region (Mok et al.,
2004a). Pcm mice suffered semidominant spleen regression,
which resulted from apoptotic cell death attributed to over-
expression of FPN1 and decreased iron levels in this tissue
(Mok et al., 2004b). The phenotypes of Pcm mice also included
a transient hypochromic and microcytic anemia that spontane-
ously corrected in young adult mice, where the correction
correlated with increased hepcidin expression (Mok et al.,
2004a), suggesting that the conversion from FPN1B to FPN1A
expression is essential to erythroid cells, especially in the early
stages of life when hepcidin levels are not high enough to repress
ferroportin expression (Figures 5F and 5G). Although the
complete knockout of FPN1 is embryonic lethal, Pcm mice
with a partial deletion of exon 1a of FPN1 have amild phenotype,
suggesting that expression of FPN1B can compensate well for
the loss of FPN1A in most physiological functions.(E) Western blot showed that ferroportin was highly expressed in erythroid cells. TfR1 was used as a positive control for erythroid cells and a-tubulin was used as
a loading control.
(F) FPN1B expression significantly decreased during erythroid cell differentiation. qRT-PCRwas used to check the gene expression in G1E-ER4 cells at 6, 12, 24,
36, 48, 60, and 72 hr after the addition of 10 nMof estradiol to induce cell differentiation. The expression levels of these genes were normalized with actin. Data are
presented as mean ± SD.
(G) Western blot revealed that ferroportin protein decreased with differentiation of G1E-ER4 cells after addition of estradiol, whereas TfR1 and FtL expression
increased with differentiation.
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FPN1B Transcript in Duodenal and Erythroid CellsAnalysis of the expression of FPN1B in erythroid lineage cells
has enabled us to discern which FPN1 transcript encodes FPN1
protein by comparing amounts of transcript and protein at
different stages of synchronously induced differentiation. The
observation that levels of FPN1 protein correlate with FPN1B
transcript levels in sorted erythroid cells and in differentiating
G1E-ER4 cells, but not with levels of FPN1A transcript, suggests
that FPN1B is functional and encodes most of the ferroportin
protein generated, whereas FPN1A is repressed and has negli-
gible contribution to ferroportin production. Similarly, even
though FPN1B transcript accounts for only 20% of the total
FPN1 mRNA in the duodenum, it may contribute significantly
to enterocytic ferroportin production.
Enterocytes differ from other cells because enterocytes must
provide iron to satisfy systemic iron demands regardless of
whether enterocytes themselves are iron depleted. Whereas
FPN1A can be repressed by IRE/IRP machinery, FPN1B is not
regulated by the IRE/IRP system and is therefore likely to be
important in enterocytic iron transport, especially when cells
are iron deficient (Figures 3 and 4). Our results offer a clear ratio-
nale for why FPN1B is significantly expressed in duodenum
(Figures 3A and 3B) and allow us to introduce an important
modification to the existing model of duodenal iron uptake,
which expands the hepcidin-ferroportin interaction model to
explain not only how iron overload is prevented but also how
duodenal iron absorption can continue in iron-deficient animals.
In iron-replete conditions (Figure 7A), both FPN1A and FPN1B
transcripts are translated into FPN1 protein, which traffics to
the basolateral membrane to transport iron into the circulation.
Once the body senses that iron stores are high, the liver
produces hepcidin, which causes ferroportin degradation and
blocks iron absorption (Nemeth et al., 2004). In iron-deficient
conditions (Figure 7B), hepcidin expression decreases and the
systemic iron-uptake blockage created by degradation of
FPN1 is eliminated. However, iron deficiency activates the IRE/
IRP system, which then represses FPN1A translation. During
iron deficiency, expression of FPN1B increases markedly (as
does FPN1A) and its ability to be translated into protein, regard-
less of IRP repressor activity, likely enables it to generate enough
FPN1 to satisfy systemic iron demands.
In erythroid precursor cells, FPN1B mRNA levels drive
ferroportin protein expression to levels higher than those in
macrophages, which are known for high ferroportin expression
(Figures 5D and 5E). The FPN1B promoter is regulated by
GATA and EKLF transcription factors, and GATA1 and EKLF
contribute to regulation of most erythroid-specific genes,
including hemoglobin and TfR1, suggesting that iron homeo-
stasis and red blood cell production are coordinately regulated470 Cell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc.in erythroid precursor cells. Although the promoter of FPN1A is
ubiquitously expressed, the FPN1B promoter is specifically
expressed in duodenum and erythroid cells. The regulation of
the FPN1B promoter by GATA and EKLF factors and its downre-
gulation during erythroid cell differentiation suggest that
erythroid cells need FPN1B to evade IRP/IRE repression and
to export iron in erythroid precursor cells during the critical
time period when cells commit to proliferation and differentia-
tion. However, once the cells begin to produce hemoglobin,
FPN1B expression diminishes and FPN1A predominates, which
allows erythroid cells to limit iron export through the IRE/IRP
system and to efficiently manufacture heme without developing
microcytic anemia, as was observed in Pcmmice that almost do
not express FPN1A.
Here, we propose that expression of FPN1B in erythroid
precursor cells enhances both sensing of serum iron status
and sensitivity to systemic iron status signals. By actively taking
up (through TfR1) and exporting (by ferroportin translated from
FPN1B) iron, erythroid precursor cells are rendered more sensi-
tive to subtle shifts in systemic iron balance and these shifts may
ultimately determine whether the pluripotent cells commit to
expansion and differentiation. For example, CFU-E cells will
suffer developmental arrest when transferrin saturations subtly
decrease, whereas other cell types such as lymphoid cells and
megakaryocytes continue to develop (Kimura et al., 1986; Good-
nough et al., 2000). In addition, the unattenuated expression of
ferroportin in erythroid cells provides a possibility that the poten-
tial systemic iron regulator hepcidin is able to regulate the
erythroid cell iron status and production, as suggested by the
phenotype of the Pcmmice. By expressing FPN1B, the erythroid
cells can express an iron exporter that is not regulated by intra-
cellular iron, but is subject to regulation by systemic iron levels
that are reflected by hepcidin expression. When systemic iron
levels are high, the Tf/TfR1 cycle will absorb more iron into cells
and increased hepcidin will block ferroportin from exporting iron
out of erythroid cells, leading to increased hemoglobin and red
cell production (Figure 7C). A model for the physiological role
of FPN1B in erythroid cells is presented in Figures 7C and 7D.
The potential crosstalk between hepcidin and ferroportin and
their physiological roles in erythroid cells warrants further inves-
tigation.
In summary, our results demonstrate that FPN1B is specifi-
cally expressed in duodenal enterocytes and in erythroid
precursor cells. In the duodenum, FPN1B could enable entero-
cytes to evade the repression by IRP/IRE machinery to export
iron into the circulation of iron-deficient animals to fulfill systemic
demands, whereas, in erythroid precursors, expression of
FPN1B likely enhances real-time sensing of systemic iron statusFigure 6. The FPN1B Promoter Was Regulated by Putative GATA and KLF Transcriptional Elements
(A) Alignment of promoter region of mouse and human FPN1B. Sequences in black boxes indicate the consensus transcription factor binding sites, the sequence
in gray indicates the new exon 1, and the asterisks indicate conserved sequences between human and mouse.
(B) The FPN1B promoter construct displayed high activity in MEL and K562 cells, whereas FPN1A promoter displayed promoter activity in all of the cells tested.
Empty pGL4-luciferase vector was used as a control. Data are presented as mean ± SD.
(C) Serial deletion assays in MEL cells showed that the FPN1B promoter was located within a 133 bp region before the transcription initiation site.
(D) Site-specific mutations in MEL cells showed that a GATA-114 site and a EKLF/GKLF/SP1-71 site were essential for FPN1B promoter activity. The left panels
showed the full sequence inserted in the pGL4 luciferase vector, from 1000 bp before to 50 bp after the transcription initiation site, the small black boxes (arrows)
indicate the putative transcription factor binding sites, and the white boxes indicate sites at which a consensus transcription factor binding site wasmutagenized.
The wild-type (WT) construct was taken as 100% promoter activity. Data are presented as mean ± SD.
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FPN1B Transcript in Duodenal and Erythroid CellsFigure 7. A Model for the Physiological Roles of the FPN1B Transcript in the Duodenal Enterocytes and Erythroid Precursor Cells
In duodenal enterocytes, FPN1 transports iron across the basolateralmembrane to bind to transferrin in theblood stream, facilitated by the ferroxidasehephaestin (Hp).
(A) In iron-replete conditions, the liver senses body iron stores as reflected by transferrin saturation levels, and hepatocytes secrete high amounts of the
iron-regulatory hormone hepcidin. In the duodenum, hepcidin is thought to bind to FPN1 and to thereby induce FPN1 internalization and degradation. Intracel-
lularly, IRPs are inactivated in iron-replete animals and both FPN1A and FPN1B can freely be translated into FPN1 protein.
(B) In iron-deficient conditions, the liver ceases to produce hepcidin in response to the low levels of circulating iron. Therefore the hepcidin-dependent
degradation of FPN1 is eliminated. However, in iron-depleted cells, IRPs bind to the 50IRE of FPN1A and repress the synthesis of FPN1 protein. Nevertheless,
as levels of FPN1B transcript increase in iron deficiency, translation of FPN1B is not repressed by IRPs, and continued FPN1 expression allows sufficient iron
export to satisfy the systemic iron demands of iron-deficient animals. In erythroid precursor cells, the Tf/TfR1 cycle actively transports iron into cells, and
FPN1 generated mainly from FPN1B exports iron to Tf, facilitated by ceruloplasmin (CP). By active uptake and export of iron, erythroid precursor cells can
precisely sense systemic iron levels and can determine whether erythropoietic expansion is warranted.
(C) In iron-replete conditions, the Tf/TfR1 cycle transports more iron into the intracellular iron pool, and increased hepcidin expression likely blocks FPN1 from
exporting iron out of cells, which increases intracellular iron levels and enhances red cell production and heme synthesis.
(D) In iron-depleted conditions, because of decreased iron uptake from the Tf/TfR1 cycle and increased iron export from FPN1, diminished iron availability results




All animals used in the procedures were approved by the institutional review
board of the animal care committee. For details, see the Supplemental Exper-
imental Procedures.Immunohistochemistry and Prussian Blue Staining
Immunohistochemistry was performed with paraffin-embedded tissue
sections (5 mm) with Map23 rabbit anti-mouse FPN1 antibody at 1:100 dilution
(raised by peptide 165–181 of mouse FPN1 in rabbit) (Wu et al., 2004). Prussian
blue staining was performed as described previously (LaVaute et al., 2001). For
details, see the Supplemental Experimental Procedures.
RACE and Promoter Analysis
RACE assays were performed with the Marathon-Ready mouse cDNA library
derived from spleen (Clontech Laboratories, Inc.) according to theCell Metabolism 9, 461–473, May 6, 2009 ª2009 Elsevier Inc. 471
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FPN1B Transcript in Duodenal and Erythroid Cellsmanufacturer’s protocol using primers shown in Table S1. For details, see the
Supplemental Experimental Procedures.
Cell Culture and G1E Cell Induction
IEC-6 cells, CACO-2 cells, HEK293 cells, HepG2 cells, RAW264.7 cells,
and K562 cells were obtained from American Type Culture Collection. MSIE
cells were kindly provided by Dr. Robert Whitehead. G1E and G1E-ER4 cells
were a gift from Dr. Mitchell Weiss. G1E cells were erythroid precursor cells
from GATA-1 null mice. G1E-ER4 cells were G1E cells that stably expressed
a conditional GATA-1 under control of estrogen receptor ligand binding
domain, undergoing synchronous erythroid maturation upon estradiol treat-
ment (Weiss et al., 1997; Rylski et al., 2003; Welch et al., 2004). For details,
see the Supplemental Experimental Procedures.
Plasmid Preparation and Dual-Luciferase Reporter Assay
The 50UTRs of FPN1A and FPN1B were cloned and inserted into the pGL3
control vector (Promega). The promoter region of FPN1B and FPN1A were
cloned into pGL4 luciferase reporter vector (Promega). For details, see the
Supplemental Experimental Procedures.
Bone Marrow Erythroid Cells and Macrophages Isolation
Bone marrow erythroid cells (Ter119 positive) and macrophages (CD11b posi-
tive) were isolated from the femurs of approximately 4-to-6-month-old adult
wild-type mice with Dynabead biotin binder (Invitrogen) according to the
manufacturer’s protocol. For details, see the Supplemental Experimental
Procedures.
Western Blot
Western blot was performed to detect the expression of FPN1, DMT1, TfR1,
b-actin, and L- and H-ferritin. For details, see the Supplemental Experimental
Procedures.
Northern Blot
Northern blots were performed with the DIG Northern Starter Kit (Roche
Applied Science), according to the manufacturer’s protocol with two minor
modifications. For details, see the Supplemental Experimental Procedures.
In Situ Hybridization
In situ hybridization was performed using digoxigenin-labeled cRNA probes
and alkaline phosphatase detection as described (Berger and Hediger,
1998). The specific UTR parts of FPN1A (170 bp) and FPN1B (96 bp) were
cloned into the pSPT18 vector (Roche Diagnostics) (Primers shown in
Table S1) and used as templates to prepare antisense or sense probes,
respectively.
qRT-PCR and Reverse Transcriptase PCR
The total RNA was prepared with TRIzol reagent (Invitrogen); cDNA was
prepared with High-Capacity cDNA Reverse Transcription Kits (Applied Bio-
systems). For details, see the Supplemental Experimental Procedures.
Statistical Analysis
Results were expressed as mean ± SD, and all statistical analyses in this study
were done with the Student’s t test.
ACCESSION NUMBERS
Three FPN1B transcripts have been deposited in GenBank: FPN1B1 (acces-
sion number FJ207421), FPN1B2 (accession number FJ207422), and
FPN1B3 (accession number FJ207423).
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